Across the nation, resources to support medical laboratory testing are dwindling even as physicians order more tests and labs must spend to acquire new diagnostic technologies
Canada’s clinical laboratory testing marketplace has just undergone another wave of consolidation among independent medical laboratory companies that has eliminated major lab test providers in the provinces of Ontario and British Columbia.
But that’s just one trend in a nation where successive budget-cutting initiatives continue to whittle down and shrink the nation’s clinical laboratory testing infrastructure.
DATELINE: Calgary, Alberta, Canada—When it comes to regional consolidation of clinical laboratory and pathology organizations, this city at the foot of the Canadian Rockies can assert a credible claim to have achieved one of the most comprehensive consolidation comprised of hospital laboratories, academic center laboratories, and anatomic pathology laboratories seen anywhere in the world.
Officially, this unified multi-site medical laboratory organization is called Calgary Laboratory Services (CLS). Last week, your Dark Daily editor was invited to tour the main laboratory facility that CLS operates here in Calgary.
GSTS Pathology Inks Pathology Testing Services Pact with KingsPath in London
In the United Kingdom, clinical pathology laboratories are facing major changes in ownership, operation, and how they are funded. One very visible sign of these coming changes is the latest expansion in the nation’s largest public/private pathology testing joint venture that took effect just two weeks ago.
On September 24, Serco Group, plc, announced that KingsPath, the pathology service arm of the King’s College Hospital NHS Foundation Trust, was entering a pathology joint venture with GSTS Pathology. This partnership became effective on October 1.